IWT SRL - Logo
Follow us:

GMP Cleaning, Isolation and Decontamination Systems for the Pharmaceutical Industries.
CLOSE

IWT STATEMENT ON COVID-19 (CORONAVIRUS)


IWT continues to monitor the COVID-19 recommendations from Italian Regional and National Authorities carefully. To guarantee the health and safety of our associates, our customers and our partners worldwide, we have implemented the following protective and preventive measures:

  • Tecniplast S.p.A. actions and guidances – Chairman’s message (April 14th)
  • IWT srl informs that working activities proceed regularly – Managing Director’s message (March 24th)
  • IWT actions and guidances – Chairman’s message (March 9th)
  • IWT actions and guidances – Chairman’s message (February 25)
  • IWT employees best practices

The IWT website will be updated if any significant changes would occur: please read and download the attached documents.

Update: 14th April 2020

IWT 3.0: Building the future of pharma division
  Enable Sound


Products

CLEANING

Automated cleaning systems for pharmaceutical equipment, ensuring compliance, safety, and repeatable performance.

ISOLATION

Aseptic isolators for sterile processing and operator protection in ATMP and pharmaceutical production.

DECONTAMINATION

Hydrogen peroxide bio-decontamination systems for controlled environments and cleanroom compliance.

Our capabilities

IWT cleaning systems are developed in compliance with international guidelines and standards, while the mandatory validation process ensures the unit exceeds user’s requirement specifications.

Proper engineering with a perfect blend of performance, timing and cost, combined with a comprehensive set of services, allow us to deliver safe, repeatable and reliable cleaning results.


READ ALL


News

December, 2025

Why a modular isolator matters in ATMP facilities

Why a modular isolator matters in ATMP facilities In the world of Advanced Therapy Medicinal Products (ATMPs), flexibility is more than a nice-to-have — it is an operational requirement. New cell and gene therapy workflows, especially autologous processes, demand adaptable production lines, fast changeovers, and highly controlled aseptic conditions....

READ DETAILS NEWS ARCHIVE